Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis

被引:0
作者
Sanjiv Singh
Avtar Singh Gautam
机构
[1] National Institute of Pharmaceutical Education and Research,Department of Pharmacology and Toxicology
[2] Export Promotions Industrial Park (EPIP),undefined
[3] Industrial Area,undefined
来源
Current Atherosclerosis Reports | 2019年 / 21卷
关键词
LOX-1; oxLDL; Atherogenesis; Plaque development; Proatherosclerotic;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 729 条
[1]  
Ross R(1993)The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 801-809
[2]  
Lusis AJ(2000)Atherosclerosis Nature 407 233-241
[3]  
Libby P(2002)Inflammation in atherosclerosis Nature 420 868-874
[4]  
Zeya B(2016)Lectin-like oxidized low-density lipoprotein (LDL) receptor (LOX-1): a chameleon receptor for oxidized LDL Biochemistry 55 4437-4444
[5]  
Arjuman A(2006)Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders Cardiovasc Res 69 36-45
[6]  
Chandra NC(2014)LOX-1 unlocks human plasma cell potential Immunity 41 507-508
[7]  
Mehta JL(2011)Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis Antioxid Redox Signal 15 2301-2333
[8]  
Chen J(2013)LOX-1 in atherosclerosis: biological functions and pharmacological modifiers Cell Mol Life Sci : CMLS 70 2859-2872
[9]  
Hermonat PL(2013)LOX-1, OxLDL, and atherosclerosis Mediat Inflamm 2013 904-907
[10]  
Romeo F(2000)Platelet-derived nitric oxide and coronary risk factors Hypertension 35 254-260